NKX6-2, NK6 homeobox 2, 84504

N. diseases: 47; N. variants: 8
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY
0.700 Biomarker disease GENOMICS_ENGLAND Expanding the clinical and genetic spectra of NKX6-2-related disorder. 29388673 2018
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY
0.700 Biomarker disease GENOMICS_ENGLAND Mutations in NKX6-2 Cause Progressive Spastic Ataxia and Hypomyelination. 28575651 2017
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY
0.700 GeneticVariation disease UNIPROT Mutations in NKX6-2 Cause Progressive Spastic Ataxia and Hypomyelination. 28575651 2017
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY
0.700 Biomarker disease GENOMICS_ENGLAND Mutations in NKX6-2 Cause Progressive Spastic Ataxia and Hypomyelination. 28575651 2017
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY
0.700 GermlineCausalMutation disease ORPHANET Mutations in NKX6-2 Cause Progressive Spastic Ataxia and Hypomyelination. 28575651 2017
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY
0.700 Biomarker disease GENOMICS_ENGLAND CNS myelin paranodes require Nkx6-2 homeoprotein transcriptional activity for normal structure. 15601927 2004
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY
0.700 CausalMutation disease CLINVAR
CUI: C0023520
Disease: Leukodystrophy
Leukodystrophy
0.120 GeneticVariation disease BEFREE Eleven new cases from eight families of different ethnic backgrounds carrying compound heterozygous and homozygous pathogenic variants in NKX6-2 were identified, evidencing a high NKX6-2 mutation burden in the hypomyelinating leukodystrophy disease spectrum. 31509304 2020
CUI: C0023520
Disease: Leukodystrophy
Leukodystrophy
0.120 GeneticVariation disease BEFREE We report on the identification of biallelic inactivating mutations in NKX6-2, a gene encoding a transcription factor regulating multiple developmental processes with a main role in oligodendrocyte differentiation and regulation of myelin-specific gene expression, as the cause underlying a previously unrecognized severe variant of hypomyelinating leukodystrophy. 28969374 2017
CUI: C0023520
Disease: Leukodystrophy
Leukodystrophy
0.120 Biomarker disease HPO
CUI: C0028738
Disease: Nystagmus
Nystagmus
0.110 GeneticVariation disease BEFREE NKX6-2 mutations should be considered in patients with autosomal recessive, very early onset of nystagmus, cerebellar ataxia with hypotonia that rapidly progresses to spasticity, particularly when associated with neuroimaging signs of hypomyelination. 31509304 2020
CUI: C0036572
Disease: Seizures
Seizures
0.110 AlteredExpression phenotype BEFREE The phenotypic and neuroimaging expression in NKX6-2 is described and it is shown that phenotypes with epilepsy in the absence of overt hypomyelination and diffuse hypomyelination without seizures can occur. 31509304 2020
CUI: C0028738
Disease: Nystagmus
Nystagmus
0.110 Biomarker disease HPO
CUI: C0036572
Disease: Seizures
Seizures
0.110 Biomarker phenotype HPO
CUI: C0004134
Disease: Ataxia
Ataxia
0.100 Biomarker phenotype HPO
CUI: C0013362
Disease: Dysarthria
Dysarthria
0.100 Biomarker disease HPO
CUI: C0013421
Disease: Dystonia
Dystonia
0.100 Biomarker phenotype HPO
CUI: C0019572
Disease: Hirsutism
Hirsutism
0.100 Biomarker phenotype HPO
CUI: C0026838
Disease: Muscle Spasticity
Muscle Spasticity
0.100 Biomarker phenotype HPO
CUI: C0036439
Disease: Scoliosis, unspecified
Scoliosis, unspecified
0.100 Biomarker disease HPO
CUI: C0038379
Disease: Strabismus
Strabismus
0.100 Biomarker disease HPO
CUI: C0151889
Disease: Hyperreflexia
Hyperreflexia
0.100 Biomarker phenotype HPO
CUI: C0234132
Disease: Pyramidal sign
Pyramidal sign
0.100 Biomarker phenotype HPO
CUI: C0235946
Disease: Cerebral atrophy
Cerebral atrophy
0.100 Biomarker disease HPO
CUI: C0311394
Disease: Difficulty walking
Difficulty walking
0.100 Biomarker phenotype HPO